SF3B1 mutations are also found in 20% of MDS cases, in which a strong enrichment is found in MDS with ring sideroblasts (18), 15% of chronic lymphocytic leukemias (47) and 6% of chronic myelomonocytic leukemia (48). Here, SF3B1 is linked to B-cell chronic lymphocytic leukemia.